FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295795034> ?p ?o ?g. }

• W4295795034 endingPage "e071215" @default.
• W4295795034 startingPage "e071215" @default.
• W4295795034 abstract "Abstract Objective To assess the performance of rapid antigen tests with unsupervised nasal and combined oropharyngeal and nasal self-sampling during the omicron period. Design Prospective cross sectional diagnostic test accuracy study. Setting Three public health service covid-19 test sites in the Netherlands, 21 December 2021 to 10 February 2022. Participants 6497 people with covid-19 symptoms aged ≥16 years presenting for testing. Interventions Participants had a swab sample taken for reverse transcription polymerase chain reaction (RT-PCR, reference test) and received one rapid antigen test to perform unsupervised using either nasal self-sampling (during the emergence of omicron, and when omicron accounted for >90% of infections, phase 1) or with combined oropharyngeal and nasal self-sampling in a subsequent (phase 2; when omicron accounted for >99% of infections). The evaluated tests were Flowflex (Acon Laboratories; phase 1 only), MPBio (MP Biomedicals), and Clinitest (Siemens-Healthineers). Main outcome measures The main outcomes were sensitivity, specificity, and positive and negative predictive values of each self-test, with RT-PCR testing as the reference standard. Results During phase 1, 45.0% (n=279) of participants in the Flowflex group, 29.1% (n=239) in the MPBio group, and 35.4% ((n=257) in the Clinitest group were confirmatory testers (previously tested positive by a self-test at own initiative). Overall sensitivities with nasal self-sampling were 79.0% (95% confidence interval 74.7% to 82.8%) for Flowflex, 69.9% (65.1% to 74.4%) for MPBio, and 70.2% (65.6% to 74.5%) for Clinitest. Sensitivities were substantially higher in confirmatory testers (93.6%, 83.6%, and 85.7%, respectively) than in those who tested for other reasons (52.4%, 51.5%, and 49.5%, respectively). Sensitivities decreased from 87.0% to 80.9% (P=0.16 by χ 2 test), 80.0% to 73.0% (P=0.60), and 83.1% to 70.3% (P=0.03), respectively, when transitioning from omicron accounting for 29% of infections to >95% of infections. During phase 2, 53.0% (n=288) of participants in the MPBio group and 44.4% (n=290) in the Clinitest group were confirmatory testers. Overall sensitivities with combined oropharyngeal and nasal self-sampling were 83.0% (78.8% to 86.7%) for MPBio and 77.3% (72.9% to 81.2%) for Clinitest. When combined oropharyngeal and nasal self-sampling was compared with nasal self-sampling, sensitivities were found to be slightly higher in confirmatory testers (87.4% and 86.1%, respectively) and substantially higher in those testing for other reasons (69.3% and 59.9%, respectively). Conclusions Sensitivities of three rapid antigen tests with nasal self-sampling decreased during the emergence of omicron but was only statistically significant for Clinitest. Sensitivities appeared to be substantially influenced by the proportion of confirmatory testers. Sensitivities of MPBio and Clinitest improved after the addition of oropharyngeal to nasal self-sampling. A positive self-test result justifies prompt self-isolation without the need for confirmatory testing. Individuals with a negative self-test result should adhere to general preventive measures because a false negative result cannot be ruled out. Manufacturers of MPBio and Clinitest may consider extending their instructions for use to include combined oropharyngeal and nasal self-sampling, and other manufacturers of rapid antigen tests should consider evaluating this as well." @default.
• W4295795034 created "2022-09-15" @default.
• W4295795034 creator A5002038535 @default.
• W4295795034 creator A5003069481 @default.
• W4295795034 creator A5006477933 @default.
• W4295795034 creator A5012886763 @default.
• W4295795034 creator A5024615976 @default.
• W4295795034 creator A5028386801 @default.
• W4295795034 creator A5029293458 @default.
• W4295795034 creator A5036600094 @default.
• W4295795034 creator A5047341769 @default.
• W4295795034 creator A5047626219 @default.
• W4295795034 creator A5050066824 @default.
• W4295795034 creator A5059159622 @default.
• W4295795034 creator A5059382011 @default.
• W4295795034 creator A5067266808 @default.
• W4295795034 creator A5068163499 @default.
• W4295795034 creator A5073648331 @default.
• W4295795034 creator A5075821786 @default.
• W4295795034 creator A5078816100 @default.
• W4295795034 creator A5083104697 @default.
• W4295795034 creator A5088740810 @default.
• W4295795034 date "2022-09-14" @default.
• W4295795034 modified "2023-09-30" @default.
• W4295795034 title "Diagnostic accuracy of covid-19 rapid antigen tests with unsupervised self-sampling in people with symptoms in the omicron period: cross sectional study" @default.
• W4295795034 cites W3020992444 @default.
• W4295795034 cites W3112440110 @default.
• W4295795034 cites W3118873013 @default.
• W4295795034 cites W3119164712 @default.
• W4295795034 cites W3138494339 @default.
• W4295795034 cites W3164388728 @default.
• W4295795034 cites W3185751529 @default.
• W4295795034 cites W3192048703 @default.
• W4295795034 cites W3192950354 @default.
• W4295795034 cites W3209779245 @default.
• W4295795034 cites W4200328944 @default.
• W4295795034 cites W4200492006 @default.
• W4295795034 cites W4206356412 @default.
• W4295795034 cites W4210691356 @default.
• W4295795034 cites W4213199075 @default.
• W4295795034 cites W4213447440 @default.
• W4295795034 cites W4221038005 @default.
• W4295795034 doi "https://doi.org/10.1136/bmj-2022-071215" @default.
• W4295795034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36104069" @default.
• W4295795034 hasPublicationYear "2022" @default.
• W4295795034 type Work @default.
• W4295795034 citedByCount "15" @default.
• W4295795034 countsByYear W42957950342022 @default.
• W4295795034 countsByYear W42957950342023 @default.
• W4295795034 crossrefType "journal-article" @default.
• W4295795034 hasAuthorship W4295795034A5002038535 @default.
• W4295795034 hasAuthorship W4295795034A5003069481 @default.
• W4295795034 hasAuthorship W4295795034A5006477933 @default.
• W4295795034 hasAuthorship W4295795034A5012886763 @default.
• W4295795034 hasAuthorship W4295795034A5024615976 @default.
• W4295795034 hasAuthorship W4295795034A5028386801 @default.
• W4295795034 hasAuthorship W4295795034A5029293458 @default.
• W4295795034 hasAuthorship W4295795034A5036600094 @default.
• W4295795034 hasAuthorship W4295795034A5047341769 @default.
• W4295795034 hasAuthorship W4295795034A5047626219 @default.
• W4295795034 hasAuthorship W4295795034A5050066824 @default.
• W4295795034 hasAuthorship W4295795034A5059159622 @default.
• W4295795034 hasAuthorship W4295795034A5059382011 @default.
• W4295795034 hasAuthorship W4295795034A5067266808 @default.
• W4295795034 hasAuthorship W4295795034A5068163499 @default.
• W4295795034 hasAuthorship W4295795034A5073648331 @default.
• W4295795034 hasAuthorship W4295795034A5075821786 @default.
• W4295795034 hasAuthorship W4295795034A5078816100 @default.
• W4295795034 hasAuthorship W4295795034A5083104697 @default.
• W4295795034 hasAuthorship W4295795034A5088740810 @default.
• W4295795034 hasBestOaLocation W42957950341 @default.
• W4295795034 hasConcept C106131492 @default.
• W4295795034 hasConcept C126322002 @default.
• W4295795034 hasConcept C140779682 @default.
• W4295795034 hasConcept C142052008 @default.
• W4295795034 hasConcept C142724271 @default.
• W4295795034 hasConcept C147483822 @default.
• W4295795034 hasConcept C203014093 @default.
• W4295795034 hasConcept C2779134260 @default.
• W4295795034 hasConcept C3007834351 @default.
• W4295795034 hasConcept C3008058167 @default.
• W4295795034 hasConcept C31972630 @default.
• W4295795034 hasConcept C41008148 @default.
• W4295795034 hasConcept C44249647 @default.
• W4295795034 hasConcept C524204448 @default.
• W4295795034 hasConcept C71924100 @default.
• W4295795034 hasConceptScore W4295795034C106131492 @default.
• W4295795034 hasConceptScore W4295795034C126322002 @default.
• W4295795034 hasConceptScore W4295795034C140779682 @default.
• W4295795034 hasConceptScore W4295795034C142052008 @default.
• W4295795034 hasConceptScore W4295795034C142724271 @default.
• W4295795034 hasConceptScore W4295795034C147483822 @default.
• W4295795034 hasConceptScore W4295795034C203014093 @default.
• W4295795034 hasConceptScore W4295795034C2779134260 @default.
• W4295795034 hasConceptScore W4295795034C3007834351 @default.
• W4295795034 hasConceptScore W4295795034C3008058167 @default.
• W4295795034 hasConceptScore W4295795034C31972630 @default.
• W4295795034 hasConceptScore W4295795034C41008148 @default.

• next